Radiotherapy as salvage or consolidation therapy in advanced epithelial ovarian cancer

  • G. M. Thomas


Survival results after treatment of advanced epithelial ovarian cancer are disappointing. While cisplatin alone or in combination produces response rates of approximately 60–80% in advanced disease, the initial optimism that overall cure rates in ovarian cancer would be substantially improved has not been fulfilled. The duration of relapse-free time has been increased over that achieved with single agent alkylating agents, but only 5–10% more patients are long term disease-free survivors [1]. Overall cure rates in advanced disease remain about 20–30% [2–4]. One strategy that has been generally pursued in improving treatment outcomes in solid tumours has been to attempt to combine effective therapies sequentially or concurrently, particularly if their toxicities are non-overlapping.


Ovarian Cancer Ovarian Carcinoma Epithelial Ovarian Cancer Minimal Residual Disease Advanced Ovarian Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Neijt, J.P., ten Bokkel Huinink, W.W., van den Burg, M.E.L. et al (1991) Long term results of chemotherapy in advanced (FIGO Stages III or IV) ovarian cancer. Int. Gynecol Cancer Soc., (abstract), 36.Google Scholar
  2. 2.
    Neijt, J.P., ten Bokkel Huinink, W.W., van den Burg, M.E.L. et al (1987) Randomized trial comparing two combination chemotherapy regimens (CHAP-5 vs CP) in advanced ovarian carcinoma, J. Clin. Oncol. 51157–68.PubMedGoogle Scholar
  3. 3.
    Vogl, S.E., Pagano, M., Kaplan, B.H. et al. (1983) Cisplatin based combination chemotherapy for advanced ovarian cancer: high overall response rate with curative potential only in women with small tumour burdens. Cancer 512024–30.PubMedCrossRefGoogle Scholar
  4. 4.
    Omura, G.A., Blessing, J.A., Ehrlich, C.E. et al. (1986) A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma: a Gynecologic Oncology Group study.Cancer 571725–30.PubMedCrossRefGoogle Scholar
  5. 5.
    Dembo, A.J. (1984) Abdominopelvic radiotherapy in ovarian cancer: a 10-year experience. Cancer 55,2285–90.CrossRefGoogle Scholar
  6. 6.
    Fuks, Z., Rizel, S. and Biran, S. (1988) Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of Stage III ovarian carcinoma. J. Clin. Oncol 6, 509–16.PubMedGoogle Scholar
  7. 7.
    Bruzzone, M., Repetto, L., Chiara, S. et al. (1990) Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol. Oncol 38,392–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Lambert, H.E., Rustin, G.J.S., Gregory, W.M. and Nelstrop, A.E. (1993) A randomised trial comparing single agent carbo- platin with carboplatin followed by radiotherapy for advanced ovarian cancer. A North Thames Ovary Group Study.J. Clin. Oncol 11, 440–8.PubMedGoogle Scholar
  9. 9.
    Mangioni, C., Epis, A., Vassena, L. et al (1987) Radiotherapy (RT) versus chemotherapy (CH) as second line treatment of minimal residual disease (MRD) in advanced epithelial ovarian cancer (EOC) Proceedings of the International Gynecological Cancer Society October, Amsterdam.Google Scholar
  10. 10.
    Lawton, P., Luesley, D., Blackledge, G. et al (1990) A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group Trial II. Clin. Oncol 2,4–9.CrossRefGoogle Scholar
  11. 11.
    Hacker, N.F., Berek, J.S., Burnison, C.M. et al (1985) Whole abdominal radiation as salvage therapy for epithelial ovarian cancer. Obstet. Gynecol 6560–6.PubMedGoogle Scholar
  12. 12.
    Chiara, S., Orsatti, M., Pranzone, P. et al (1991) Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer. Clin. Oncol 3,340–4.CrossRefGoogle Scholar
  13. 13.
    Peters III W.A., Blasko, J.C., Bagley Jr, C.M. et al (1986) Salvage therapy with whole- abdominal irradiation in patients with advanced carcinoma of the ovary previously treated by combination chemotherapy. Cancer 58880–2.PubMedCrossRefGoogle Scholar
  14. 14.
    Hoskins, W.J., Lichter, A.S., Whittington, R. et al (1985) Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma. Gynecol Oncol 20271–80.PubMedCrossRefGoogle Scholar
  15. 15.
    Greiner, R., Goldhirsch, A., Davis, B.W. et al (1984) Whole-abdomen radiation in patients with advanced ovarian carcinoma after surgery, chemotherapy and second-look laparotomy. J. Cancer Res. Clin. Oncol 107, 94–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Piver, M.S., Barlow, J.J., Lee, P.T. and Vongtama, V. (1975) Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy and radiation therapy. Am. J. Obstet, Gynecol 122, 355–7.Google Scholar
  17. 17.
    Hainsworth, J.D., Malcolm, A., Johnson, D.H. et al (1983) Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy. Obstet. Gynecol 61, 619–23.PubMedGoogle Scholar
  18. 18.
    Schray, M.F., Martinez, A., Howes, A.E. et al (1988) Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy. J. Clin. Oncol 61433–9.PubMedGoogle Scholar
  19. 19.
    Reddy, S., Hartsell, W., Graham, J. et al (1989)Whole-abdomen radiation therapy in ovarian carcinoma: its role as a salvage therapeutic modality. Gynecol Oncol 35 307–13.PubMedCrossRefGoogle Scholar
  20. 20.
    Kuten, A., Stein, M., Steiner, M. et al. (1988) Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma.Int. J. Radiat. Oncol. Biol. Phys. 14 273–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Linstadt, D.E., Stern, J.L., Quivey, J.M. et al. (1990) Salvage whole-abdominal irradiation following chemotherapy failure in epithelial ovarian carcinoma. Gynecol. Oncol. 36, 327–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Solomon, H.J., Atkinson, K.H., Coppleson, J.V.M. et al. (1988) Ovarian carcinoma: abdominopelvic irradiation following reexploration. Gynecol. Oncol 31 396–401.PubMedCrossRefGoogle Scholar
  23. 23.
    Kong, J.S., Peters, L.J., Wharton, J.T. et al (1988) Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity. Int. J. Radiat. Oncol Biol Phys. 14 737–43.PubMedCrossRefGoogle Scholar
  24. 24.
    Rosen, E.M., Goldberg, I.D., Rose, C. et al (1986) Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma. Radiother. Oncol 1 223–32.CrossRefGoogle Scholar
  25. 25.
    Rothenberg, M.L., Ozols, R.F., Glatstein, E. et al (1992) Dose-intensive induction therapy with cyclophosphamide, cisplatin, and con- solidative abdominal radiation in advanced- stage epithelial ovarian cancer.J. Clin. Oncol 10 727–34.PubMedGoogle Scholar
  26. 26.
    Haie, C., Pejovic-Lenfant, M.H., George, M. et al (1989) Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma. Int. J. Radiat. Oncol Biol Phys. 1715–19.PubMedCrossRefGoogle Scholar
  27. 27.
    Cain, J.M., Russell, A.H., Greer, B.E. et al (1988) Whole abdomen radiation for minimal residual epithelial ovarian carcinoma after surgical resection and maximal first-line chemotherapy. Gynecol Oncol 29168–75.PubMedCrossRefGoogle Scholar
  28. 28.
    Kersh, C.R., Randall, M.E., Constable, W.C. et al (1988) Whole abdominal radiotherapy following cytoreductive surgery and chemotherapy in ovarian carcinoma. Gynecol Oncol 31,113–20.PubMedCrossRefGoogle Scholar
  29. 29.
    Goldhirsch, A., Greiner, R., Dreher, E. et al (1988) Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy. Cancer 62, 40–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Rustin, G.J.S., Minton, M., Southcott, B. et al (1987) Surgery, chemotherapy and whole abdominal radiotherapy in the management of advanced ovarian carcinoma. Clin. Radiol 38,269–72.PubMedCrossRefGoogle Scholar
  31. 31.
    Menczer, J., Modan, M., Brenner, J. et al (1986) Abdominopelvic irradiation for Stage II-IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy. Gynecol Oncol 24, 149–54.PubMedCrossRefGoogle Scholar
  32. 32.
    Morgan, L., Chafe, W., Mendenhall, W. and Marcus, R. (1988) Hyperfractionation of whole- abdomen radiation therapy: salvage treatment of persistent ovarian carcinoma following chemotherapy. Gynecol Oncol 31122–34.PubMedCrossRefGoogle Scholar
  33. 33.
    Coltart, R.S., Nethersell, A.B.W. and Brown C.H. (1986) A pilot study of high dose abdominopelvic radiotherapy following surgery and chemotherapy for Stage III epithelial carcinoma of the ovary. Gynecol Oncol 23105–10.PubMedCrossRefGoogle Scholar
  34. 34.
    Shelly, W.E., Carmichael, J.C., Brown, L.B. et al (1988) Adriamycin and cisplatin in the treatment of Stage III and IV epithelial ovarian carcinoma. Gynecol Oncol 29208–21.CrossRefGoogle Scholar
  35. 35.
    Dembo, A.J. and Bush, R.S. (1982) Choice of postoperative therapy based on prognostic factors. Int. J. Radiat. Oncol Biol Phys. 8, 893–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Dembo, A.J., Bush, R.S. and Brown, T.C. (1982) Clinicopathological correlates in ovarian cancer. Bulletin du Cancer (Paris) 69292–8.Google Scholar
  37. 37.
    Carey, M., Dembo, A.J., Fyles, A.W. and Simm, J. (1993) Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year review. Int. J. Gynecol Cancer 3 24–35.PubMedCrossRefGoogle Scholar
  38. 38.
    Lindner, H., Willich, H. and Atzinger, A. (1990) Primary adjuvant whole abdominal irradiation in ovarian carcinoma. Int. J. Radiat. Oncol Biol Phys. 191203–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Ledermann, J.A., Dembo, A.J., Sturgeon, J.F.G. et al (1991) Outcome of patients with unfavourable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation. Gynecol Oncol 41 30–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Whelan, T.J., Dembo, A.J., Bush, R.S. et al (1992) Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int. J. Radiat. Oncol Biol Phys. 22,853–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Hoskins, W.J., Rubin, S.C. (1991) Surgery in the treatment of patients with advanced ovarian cancer. Semin. Oncol 18213–21.PubMedGoogle Scholar
  42. 42.
    Louie, K.G., Behrens, B.C., Kinsella, T.J. et al (1985) Radiation survival parameters of anti- neoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res. 452110–15.PubMedGoogle Scholar
  43. 43.
    Withers, H.R., Taylor, J.M.G. and Maciejewski, B. (1988) The hazard of accelerated tumour donogen repopulation during radiotherapy. Acta Oncol 27,131–46.PubMedCrossRefGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • G. M. Thomas

There are no affiliations available

Personalised recommendations